US Stock MarketDetailed Quotes

TNXP Tonix Pharmaceuticals

Watchlist

0.3400
+0.0098+2.97%

Close Aug 23 16:00 ET

0.3401
+0.0001+0.03%

Post 20:01 ET

7.48MMarket Cap-22P/E (TTM)

Tonix Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

2.21M

2.48M

7.77M

3.78M

3.99M

Operating revenue

--2.21M

--2.48M

--7.77M

--3.78M

--3.99M

--0

Cost of revenue

3.37M

1.66M

4.74M

2.37M

Gross profit

-1.16M

822K

3.03M

1.41M

1.62M

Operating expense

-40.69%17.2M

-34.60%22.17M

8.31%121.41M

-12.18%28.74M

0.58%29.76M

24.28%29M

28.24%33.9M

21.43%112.09M

11.02%32.73M

59.65%29.59M

Selling and administrative expenses

6.77%7.5M

25.96%9.31M

15.02%34.75M

44.29%11.62M

17.89%8.71M

3.98%7.03M

-7.77%7.39M

28.72%30.22M

12.13%8.05M

35.52%7.39M

-General and administrative expense

6.77%7.5M

25.96%9.31M

15.02%34.75M

----

3.98%7.03M

-7.77%7.39M

28.72%30.22M

----

Research and development costs

-55.87%9.7M

-51.48%12.86M

5.84%86.66M

-30.62%17.12M

-5.18%21.05M

32.55%21.98M

43.91%26.51M

18.94%81.88M

10.67%24.67M

69.71%22.2M

Operating profit

36.70%-18.36M

37.02%-21.35M

-5.61%-118.38M

16.50%-27.33M

4.88%-28.15M

-24.28%-29M

-28.24%-33.9M

-21.43%-112.09M

-11.02%-32.73M

-59.65%-29.59M

Net non-operating interest income expense

-71.80%172K

8,614.29%610K

Non-operating interest income

----

-71.80%172K

----

8,614.29%610K

Other net income (expense)

-9,452.48%-60.42M

614.83%6.41M

-8.06%1.72M

646K

897K

1.87M

Gain on sale of security

---855K

--7.01M

----

Special income (charges)

---58.96M

----

--0

----

-Less:Impairment of capital assets

--58.96M

----

--0

----

Other non- operating income (expenses)

-193.65%-605K

-166.11%-593K

-8.06%1.72M

----

--646K

--897K

--1.87M

----

Income before tax

-177.81%-78.78M

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

-19.43%-110.22M

-7.20%-31.68M

-56.42%-28.98M

Income tax

Net income

-177.81%-78.78M

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

-19.43%-110.22M

-7.20%-31.68M

-56.42%-28.98M

Net income continuous Operations

-177.81%-78.78M

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

-19.43%-110.22M

-7.20%-31.68M

-56.42%-28.98M

Minority interest income

Net income attributable to the parent company

-177.81%-78.78M

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

-19.43%-110.22M

-7.20%-31.68M

-56.42%-28.98M

Preferred stock dividends

6.66M

2.4M

Other preferred stock dividends

Net income attributable to common stockholders

-177.81%-78.78M

54.74%-14.94M

0.19%-116.66M

19.84%-27.32M

3.47%-27.98M

-3.51%-28.36M

-24.94%-33.01M

-26.65%-116.88M

-15.33%-34.08M

-56.42%-28.98M

Basic earnings per share

60.84%-19.28

94.39%-5.76

65.77%-219.2

86.68%-14.9161

56.84%-58.56

79.86%-49.23

68.10%-102.72

60.47%-640.32

75.00%-112

57.60%-135.68

Diluted earnings per share

60.84%-19.28

94.39%-5.76

65.77%-219.2

86.68%-14.9161

56.84%-58.56

79.86%-49.23

68.10%-102.72

60.47%-640.32

75.00%-112

57.60%-135.68

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	2.21M	2.48M	7.77M	3.78M	3.99M	0	0	0	0	0
Operating revenue	--2.21M	--2.48M	--7.77M	--3.78M	--3.99M	--0	--0	--0	--0	--0
Cost of revenue	3.37M	1.66M	4.74M	2.37M	2.37M	0	0	0	0	0
Gross profit	-1.16M	822K	3.03M	1.41M	1.62M	0	0	0	0	0
Operating expense	-40.69%17.2M	-34.60%22.17M	8.31%121.41M	-12.18%28.74M	0.58%29.76M	24.28%29M	28.24%33.9M	21.43%112.09M	11.02%32.73M	59.65%29.59M
Selling and administrative expenses	6.77%7.5M	25.96%9.31M	15.02%34.75M	44.29%11.62M	17.89%8.71M	3.98%7.03M	-7.77%7.39M	28.72%30.22M	12.13%8.05M	35.52%7.39M
-General and administrative expense	6.77%7.5M	25.96%9.31M	15.02%34.75M	----	----	3.98%7.03M	-7.77%7.39M	28.72%30.22M	----	----
Research and development costs	-55.87%9.7M	-51.48%12.86M	5.84%86.66M	-30.62%17.12M	-5.18%21.05M	32.55%21.98M	43.91%26.51M	18.94%81.88M	10.67%24.67M	69.71%22.2M
Operating profit	36.70%-18.36M	37.02%-21.35M	-5.61%-118.38M	16.50%-27.33M	4.88%-28.15M	-24.28%-29M	-28.24%-33.9M	-21.43%-112.09M	-11.02%-32.73M	-59.65%-29.59M
Net non-operating interest income expense					-71.80%172K					8,614.29%610K
Non-operating interest income	----	----	----	----	-71.80%172K	----	----	----	----	8,614.29%610K
Other net income (expense)	-9,452.48%-60.42M	614.83%6.41M	-8.06%1.72M			646K	897K	1.87M
Gain on sale of security	---855K	--7.01M	----	----	----	----	----	----	----	----
Special income (charges)	---58.96M	----	----	----	----	--0	----	----	----	----
-Less:Impairment of capital assets	--58.96M	----	----	----	----	--0	----	----	----	----
Other non- operating income (expenses)	-193.65%-605K	-166.11%-593K	-8.06%1.72M	----	----	--646K	--897K	--1.87M	----	----
Income before tax	-177.81%-78.78M	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M	-19.43%-110.22M	-7.20%-31.68M	-56.42%-28.98M
Income tax
Net income	-177.81%-78.78M	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M	-19.43%-110.22M	-7.20%-31.68M	-56.42%-28.98M
Net income continuous Operations	-177.81%-78.78M	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M	-19.43%-110.22M	-7.20%-31.68M	-56.42%-28.98M
Minority interest income
Net income attributable to the parent company	-177.81%-78.78M	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M	-19.43%-110.22M	-7.20%-31.68M	-56.42%-28.98M
Preferred stock dividends								6.66M	2.4M
Other preferred stock dividends
Net income attributable to common stockholders	-177.81%-78.78M	54.74%-14.94M	0.19%-116.66M	19.84%-27.32M	3.47%-27.98M	-3.51%-28.36M	-24.94%-33.01M	-26.65%-116.88M	-15.33%-34.08M	-56.42%-28.98M
Basic earnings per share	60.84%-19.28	94.39%-5.76	65.77%-219.2	86.68%-14.9161	56.84%-58.56	79.86%-49.23	68.10%-102.72	60.47%-640.32	75.00%-112	57.60%-135.68
Diluted earnings per share	60.84%-19.28	94.39%-5.76	65.77%-219.2	86.68%-14.9161	56.84%-58.56	79.86%-49.23	68.10%-102.72	60.47%-640.32	75.00%-112	57.60%-135.68
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall